Swissmedic On Project Orbis: Faster Access To Drugs, Valuable Scientific Discussions

In the first of a two-part interview with the Pink Sheet, an expert from the Swiss drug regulator explains why international collaborations are “the future” and outlines the agency’s “extremely positive” experience since joining the Project Orbis initiative three years ago.

Swiss flag pills — • Source: Shutterstock

The US-led Project Orbis was initiated by the Food and Drug Administration in May 2019, with the aim of establishing a framework for international regulators to concurrently review filings for cancer drugs.

Its ultimate goal was to allow patients with cancer to receive earlier access to innovative oncology medicines by avoiding delays...